Show results for
Refine by
Preclinical Data From Cytotil15 Program Equipment Supplied In Singapore
5 equipment items found
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary infusion in patients who have suffered an acute myocardial ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-Osteo for spinal fusion is a proprietary Phase 3-ready product candidate. All doses of MPC-25-Osteo for the treatment of spinal fusion consist of 25 million MPCs delivered on a collagen ceramic carrier material into the disc space with stabilizing ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-06-ID is a Phase 3 product candidate for the treatment of chronic low back pain caused by disc degeneration (CLBP). It is being developed for patients who have exhausted conservative treatment options, may have failed epidural steroid injections and have no further treatment option other than invasive and costly surgical ...
Manufactured by:Bruker Corporation based inBillerica, MASSACHUSETTS (USA)
Designed for the emerging market of preclinical and molecular MR imaging: The BioSpec series is designed for the emerging market of preclinical and molecular MR imaging. State-of-the-art MRI CryoProbe technology together with ultra high field USR magnets deliver high spatial resolution in vivo enabling customers to come closer to the molecular and cellular level research they desire. Thanks to ...